PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)

Clinical trials for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) explained in plain language.

Never miss a new study

Get alerted when new PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) trials appear

Sign up with your email to follow new studies for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2

New balloon treatment aims to keep leg arteries open longer

Disease control Not yet recruiting

This study looks at how safe and effective a special balloon coated with paclitaxel is for people with long blockages in the leg arteries. About 300 adults with severe leg pain or early tissue damage will be treated and followed for one year. The goal is to see if the balloon kee…

Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)

Sponsor: Genoss Co., Ltd. • Aim: Disease control

Last updated May 17, 2026 15:14 UTC

PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)

Get alerted when new PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) trials appear

New balloon treatment aims to keep leg arteries open longer